-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
-
Summary
-
Ambrx Biopharma Cayman, Inc. quarterly Common Stock, Value, Issued history and change rate from Q4 2020 to Q2 2023.
- Ambrx Biopharma Cayman, Inc. Common Stock, Value, Issued for the quarter ending 30 Jun 2023 was $43K, a 59.3% increase year-over-year.
Common Stock, Value, Issued, Quarterly (USD)
Common Stock, Value, Issued, YoY Quarterly Change (%)